261 related articles for article (PubMed ID: 20205647)
1. Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence.
Szekely CA; Zandi PP
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):132-9. PubMed ID: 20205647
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease.
Cole GM; Frautschy SA
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):140-8. PubMed ID: 20205646
[TBL] [Abstract][Full Text] [Related]
3. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
Pasinetti GM
J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase as a target for the antiamyloidogenic activities of nonsteroidal anti-inflammatory drugs in Alzheimer's disease.
Pasinetti GM
Neurosignals; 2002; 11(5):293-7. PubMed ID: 12566930
[TBL] [Abstract][Full Text] [Related]
5. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C
Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410
[TBL] [Abstract][Full Text] [Related]
6. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
Doraiswamy PM
CNS Drugs; 2002; 16(12):811-24. PubMed ID: 12421115
[TBL] [Abstract][Full Text] [Related]
7. Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?
Ho L; Qin W; Stetka BS; Pasinetti GM
CNS Drugs; 2006; 20(2):85-98. PubMed ID: 16478285
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of NSAIDs on the development of Alzheimer disease.
Vlad SC; Miller DR; Kowall NW; Felson DT
Neurology; 2008 May; 70(19):1672-7. PubMed ID: 18458226
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
Gasparini L; Ongini E; Wenk G
J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
[TBL] [Abstract][Full Text] [Related]
10. Neurones treated with cyclo-oxygenase-1 inhibitors are resistant to amyloid-beta1-42.
Bate C; Veerhuis R; Eikelenboom P; Williams A
Neuroreport; 2003 Nov; 14(16):2099-103. PubMed ID: 14600505
[TBL] [Abstract][Full Text] [Related]
11. Is it All Said for NSAIDs in Alzheimer's Disease? Role of Mitochondrial Calcium Uptake.
Sanz-Blasco S; Calvo-Rodriguez M; Caballero E; Garcia-Durillo M; Nunez L; Villalobos C
Curr Alzheimer Res; 2018; 15(6):504-510. PubMed ID: 29283047
[TBL] [Abstract][Full Text] [Related]
12. Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation.
Thomas T; Nadackal TG; Thomas K
Neuroreport; 2001 Oct; 12(15):3263-7. PubMed ID: 11711868
[TBL] [Abstract][Full Text] [Related]
13. [The role of cyclooxygenases in neurotoxicity of amyloid beta peptides in Alzheimer's disease].
Cakała M; Strosznajder JB
Neurol Neurochir Pol; 2010; 44(1):65-79. PubMed ID: 20358486
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection: promise and pitfalls in anti-inflammatory treatment of Alzheimer's disease.
Memo M; Blandini F; Nappi G; Spano P
Funct Neurol; 2002; 17(4):175-6. PubMed ID: 12675259
[No Abstract] [Full Text] [Related]
15. The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease.
Imbimbo BP
Expert Opin Investig Drugs; 2004 Nov; 13(11):1469-81. PubMed ID: 15500394
[TBL] [Abstract][Full Text] [Related]
16. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D; Isaac MG; McCleery J; Tabet N
Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease.
Hoozemans JJ; Veerhuis R; Rozemuller AJ; Eikelenboom P
Curr Drug Targets; 2003 Aug; 4(6):461-8. PubMed ID: 12866660
[TBL] [Abstract][Full Text] [Related]
18. The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease.
Aisen PS
Lancet Neurol; 2002 Sep; 1(5):279-84. PubMed ID: 12849425
[TBL] [Abstract][Full Text] [Related]
19. Neuroinflammation in Alzheimer's disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy?
Trepanier CH; Milgram NW
J Alzheimers Dis; 2010; 21(4):1089-99. PubMed ID: 21504126
[TBL] [Abstract][Full Text] [Related]
20. Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models.
Joo Y; Kim HS; Woo RS; Park CH; Shin KY; Lee JP; Chang KA; Kim S; Suh YH
Mol Pharmacol; 2006 Jan; 69(1):76-84. PubMed ID: 16223958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
